164 related articles for article (PubMed ID: 27655692)
1. Serum depletion induced cancer stem cell-like phenotype due to nitric oxide synthesis in oncogenic HRas transformed cells.
Monji K; Uchiumi T; Hoshizawa S; Yagi M; Matsumoto T; Setoyama D; Matsushima Y; Gotoh K; Amamoto R; Kang D
Oncotarget; 2016 Nov; 7(46):75221-75234. PubMed ID: 27655692
[TBL] [Abstract][Full Text] [Related]
2. TRIM28 multi-domain protein regulates cancer stem cell population in breast tumor development.
Czerwińska P; Shah PK; Tomczak K; Klimczak M; Mazurek S; Sozańska B; Biecek P; Korski K; Filas V; Mackiewicz A; Andersen JN; Wiznerowicz M
Oncotarget; 2017 Jan; 8(1):863-882. PubMed ID: 27845900
[TBL] [Abstract][Full Text] [Related]
3. Oncogenic Kinase-Induced PKM2 Tyrosine 105 Phosphorylation Converts Nononcogenic PKM2 to a Tumor Promoter and Induces Cancer Stem-like Cells.
Zhou Z; Li M; Zhang L; Zhao H; Şahin Ö; Chen J; Zhao JJ; Songyang Z; Yu D
Cancer Res; 2018 May; 78(9):2248-2261. PubMed ID: 29440169
[TBL] [Abstract][Full Text] [Related]
4. Evaluating The Role Of Nitric Oxide Synthase In Oncogenic Ras-Driven Tumorigenesis.
Counter C
Redox Biol; 2015 Aug; 5():417. PubMed ID: 28162280
[TBL] [Abstract][Full Text] [Related]
5. Role of oncogenic K-Ras in cancer stem cell activation by aberrant Wnt/β-catenin signaling.
Moon BS; Jeong WJ; Park J; Kim TI; Min do S; Choi KY
J Natl Cancer Inst; 2014 Feb; 106(2):djt373. PubMed ID: 24491301
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial pyruvate carrier function determines cell stemness and metabolic reprogramming in cancer cells.
Li X; Han G; Li X; Kan Q; Fan Z; Li Y; Ji Y; Zhao J; Zhang M; Grigalavicius M; Berge V; Goscinski MA; Nesland JM; Suo Z
Oncotarget; 2017 Jul; 8(28):46363-46380. PubMed ID: 28624784
[TBL] [Abstract][Full Text] [Related]
7. Activation of sterile20-like kinase 1 in proteasome inhibitor bortezomib-induced apoptosis in oncogenic K-ras-transformed cells.
Teraishi F; Guo W; Zhang L; Dong F; Davis JJ; Sasazuki T; Shirasawa S; Liu J; Fang B
Cancer Res; 2006 Jun; 66(12):6072-9. PubMed ID: 16778179
[TBL] [Abstract][Full Text] [Related]
8. Metabolic activation of mitochondria in glioma stem cells promotes cancer development through a reactive oxygen species-mediated mechanism.
Yuan S; Lu Y; Yang J; Chen G; Kim S; Feng L; Ogasawara M; Hammoudi N; Lu W; Zhang H; Liu J; Colman H; Lee JS; Li XN; Xu RH; Huang P; Wang F
Stem Cell Res Ther; 2015 Oct; 6():198. PubMed ID: 26472041
[TBL] [Abstract][Full Text] [Related]
9. Colorectal Carcinogenesis: Connecting K-RAS-Induced Transformation and CREB Activity In Vitro and In Vivo.
Steven A; Heiduk M; Recktenwald CV; Hiebl B; Wickenhauser C; Massa C; Seliger B
Mol Cancer Res; 2015 Aug; 13(8):1248-62. PubMed ID: 25934695
[TBL] [Abstract][Full Text] [Related]
10. Increased OXPHOS activity precedes rise in glycolytic rate in H-RasV12/E1A transformed fibroblasts that develop a Warburg phenotype.
de Groof AJ; te Lindert MM; van Dommelen MM; Wu M; Willemse M; Smift AL; Winer M; Oerlemans F; Pluk H; Fransen JA; Wieringa B
Mol Cancer; 2009 Jul; 8():54. PubMed ID: 19646236
[TBL] [Abstract][Full Text] [Related]
11. Loss of mitochondrial exo/endonuclease EXOG affects mitochondrial respiration and induces ROS-mediated cardiomyocyte hypertrophy.
Tigchelaar W; Yu H; de Jong AM; van Gilst WH; van der Harst P; Westenbrink BD; de Boer RA; Silljé HH
Am J Physiol Cell Physiol; 2015 Jan; 308(2):C155-63. PubMed ID: 25377088
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide induces cancer stem cell-like phenotypes in human lung cancer cells.
Yongsanguanchai N; Pongrakhananon V; Mutirangura A; Rojanasakul Y; Chanvorachote P
Am J Physiol Cell Physiol; 2015 Jan; 308(2):C89-100. PubMed ID: 25411331
[TBL] [Abstract][Full Text] [Related]
13. DNMT1 Regulates Epithelial-Mesenchymal Transition and Cancer Stem Cells, Which Promotes Prostate Cancer Metastasis.
Lee E; Wang J; Yumoto K; Jung Y; Cackowski FC; Decker AM; Li Y; Franceschi RT; Pienta KJ; Taichman RS
Neoplasia; 2016 Sep; 18(9):553-66. PubMed ID: 27659015
[TBL] [Abstract][Full Text] [Related]
14. [Nitric oxide as an adaptive protection factor in hypoxia].
Kurgaliuk NN
Usp Fiziol Nauk; 2002; 33(4):65-79. PubMed ID: 12449808
[TBL] [Abstract][Full Text] [Related]
15. Oncogenic K-ras expression is associated with derangement of the cAMP/PKA pathway and forskolin-reversible alterations of mitochondrial dynamics and respiration.
Palorini R; De Rasmo D; Gaviraghi M; Sala Danna L; Signorile A; Cirulli C; Chiaradonna F; Alberghina L; Papa S
Oncogene; 2013 Jan; 32(3):352-62. PubMed ID: 22410778
[TBL] [Abstract][Full Text] [Related]
16. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C
Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677
[TBL] [Abstract][Full Text] [Related]
17. Targeting Cancer Stem Cells in Castration-Resistant Prostate Cancer.
Yun EJ; Zhou J; Lin CJ; Hernandez E; Fazli L; Gleave M; Hsieh JT
Clin Cancer Res; 2016 Feb; 22(3):670-9. PubMed ID: 26490309
[TBL] [Abstract][Full Text] [Related]
18. Targeting flavin-containing enzymes eliminates cancer stem cells (CSCs), by inhibiting mitochondrial respiration: Vitamin B2 (Riboflavin) in cancer therapy.
Ozsvari B; Bonuccelli G; Sanchez-Alvarez R; Foster R; Sotgia F; Lisanti MP
Aging (Albany NY); 2017 Dec; 9(12):2610-2628. PubMed ID: 29253841
[TBL] [Abstract][Full Text] [Related]
19. MYC/PGC-1α Balance Determines the Metabolic Phenotype and Plasticity of Pancreatic Cancer Stem Cells.
Sancho P; Burgos-Ramos E; Tavera A; Bou Kheir T; Jagust P; Schoenhals M; Barneda D; Sellers K; Campos-Olivas R; Graña O; Viera CR; Yuneva M; Sainz B; Heeschen C
Cell Metab; 2015 Oct; 22(4):590-605. PubMed ID: 26365176
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial retrograde signaling mediated by UCP2 inhibits cancer cell proliferation and tumorigenesis.
Esteves P; Pecqueur C; Ransy C; Esnous C; Lenoir V; Bouillaud F; Bulteau AL; Lombès A; Prip-Buus C; Ricquier D; Alves-Guerra MC
Cancer Res; 2014 Jul; 74(14):3971-82. PubMed ID: 24853548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]